Pfizer Independent Medical Education Grant Request for Proposals: Optimising Ulcerative Colitis Care
Pfizer funds medical education projects to advance clinician training in ulcerative colitis management, biomarker use, and reducing care disparities across Australia.
Funder: Pfizer Inc.
Due Dates: June 1, 2026 (Submission Deadline, full application)
Funding Amounts: Up to $150,000 AUD per project; maximum project length 1 year; total budget available is $150,000 AUD.
Summary: Funds independent medical education projects to improve ulcerative colitis care through clinician training on advanced therapies, biomarker use, and addressing health disparities.
Key Information: Applications must be submitted by 23:59 Eastern Standard Time (New York, GMT -5); only organizations in Australia are eligible.
Description
This grant opportunity supports independent medical education initiatives that enhance healthcare professionals’ knowledge and skills in managing ulcerative colitis (UC). Projects should address one or more of the following: facilitating the transition from conventional to advanced therapies (including treat-to-target strategies and use of intestinal ultrasound), educating clinicians on the use and interpretation of biomarkers for long-term management of patients on S1P receptor modulators, and addressing disparities in UC care between rural and metropolitan settings through improved access, awareness, and culturally appropriate education. The overarching goal is to bridge knowledge gaps, promote best practices, and improve patient outcomes in UC care across Australia.
